Skip to main content

astrazeneca-logo

AstraZeneca, in a move to increase its biologics manufacturing capacity in the United States, has acquired a high-tech biologics bulk manufacturing plant in Boulder, Colo., from Amgen Inc.

{iframe}http://www.bizjournals.com/philadelphia/blog/health-care/2015/09/astrazeneca-buys-boulder-amgen-facility.html?ana=e_phil_bn_newsalert&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1441987751{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.